Tumour-targeted delivery of therapeutic nanoparticles

ABOUT

Nanocapture is a translational biomedical research project. Our small pre-seed team is based at the Pharmacy Department at the Ludwig-Maximilians-Universität Munich, Germany. Supported by the GO-Bio program of the German Federal Government – BMBF, our team is aiming to significantly improve the selectivity of drug delivery during tumour chemotherapies. In our key proof-of concept studies, we could demonstrate that our lead product, NanoCap-DLV, effectively slows down tumour progression in aggressive models of pancreatic and breast cancer compared to the standard of care. 

TEAM

The NanoCapture is a multidisciplinary team with experts in chemistry, in vivo biology and oncology.

edf

DR. PETAR MARINKOVIĆ

Project Leader

Petar brings more than 10 years of experience in leading scientific projects. Together with Dr. Thorn-Seshold, he performed first proof-of-principle studies and obtained the initial funding for the project. He is responsible for the overall project strategy, as well as for the scientific and business development.

DR. JULIA AHLFELD

Scientific Lead

Julia is a scientist with a strong background in tumour pathology, neurobiology and molecular biology. In addition, she brings valuable experience in conducting and organizing clinical trials. Within the NanoCapture project, she is responsible for the in-house studies and data analysis.

bdr
IMG_6358 new

DR. ANNABEL KITOWSKI

Chemistry and analytics

Annabel comes to NanoCapture after a very successful PhD in Medical Biochemistry at Instituto de Medicina Molecular, Lisbon, Portugal. At NanoCapture, she established necessary analytical workflows to measure drug content in biological samples.

CONSTANZE HEISE

in vivo assays

Constanze is a technical assistant with extensive experience in oncology research. Within the NanoCapture project, she is responsible for running in-house in vivo assays

IMG_3109

DR. OLIVER THORN-SESHOLD

ASSOCIATED MEMBER - ADVISOR

Oliver is the inventor of the NanoCapture concept which won the 2015 Innovationsakademie competition. With the strong  background in medicinal chemistry, his main research interest is developing more selective and powerful anticancer drugs. Oliver is a junior group leader at the Pharmacy Department at LMU and remains a close advisor to the NanoCapture project.

Do you want to be part of NanoCapture?

CONTACT

Get connected to NanoCapture

NanoCapture i.Gr.
LMU München
Department Pharmazie
Butenandtstr. 1
81377 München

+49(0)89/2180-71034
Follow us: